Welcome to JADPRO’s Clinical Case Series. In each of the modules below, you can read about 3 related patient cases, answer some questions to share your perspective on the topic, and then attend a live webinar to explore the cases further and get clinical pearls from our faculty experts.
New!
Managing Patients With Chronic GVHD Across the Treatment Continuum
Faculty
Christine Rimkus, RN, MSN, AOCN
New!
Considerations in the Diagnosis and Treatment of Chronic Graft-vs-Host Disease
Faculty
Erin Kopp, DNP, ACNP-BC, BMTCN
New!
BTK Inhibitor Considerations in Chronic Lymphocytic Leukemia and Waldenström Macroglobulinemia Patient Populations
Faculty
Josie Montegaard, MSN, AGPCNP-BC
Catherine Flynn, NP
New!
Second-Line CAR T-Cell Therapy for Multiple Myeloma
Faculty
Michelle Lauer, PA-C, MPH
New!
Cytopenias, Including Transfusion-Dependent Anemia, in Myelofibrosis
Faculty
Sandra E. Kurtin, PhD, ANP-C, AOCN, FAPO
New!
Bispecific Antibodies in DLBCL: Navigating the Evolving Treatment Landscape
Faculty
Jacklyn Gideon, MSN, AGNP-BC
New!
Maintaining High Quality of Life, Good Performance Status in Refractory Colorectal Cancer
Faculty
Tammy Triglianos, DNP, ANP-BC, AOCNP
New!
Understanding Patient Goals and Risk Factors When Determining Therapy for Newly Diagnosed and Recurrent/Relapsed CLL
Faculty
Sara M. Tinsley-Vance, PhD, APRN, AOCN
New!
Managing Fertility and Treatment-related Side Effects in Premenopausal Patients with Breast Cancer
Faculty
Kelley Mayden, DNP, APRN-FNP, AOCNP
New!
Management of Patients With Multiple Myeloma Receiving CAR T-Cell Therapy: Timing, Adverse Events, and Coordination of Care (Part 1)
Faculty
Rebecca Lu, MSN, RN, FNP-C
New!
Management of Patients With Multiple Myeloma Receiving CAR T-Cell Therapy: Timing, Adverse Events, and Coordination of Care (Part 2)
Faculty
Rebecca Lu, MSN, RN, FNP-C
New!
To Extend or Not Extend? Evaluating the Need for Extended Endocrine Therapy in Patients With Early-Stage HR+ Breast Cancer
Faculty
Michelle Butaud, APRN, ANP, AOCNP, CBCN
New!
Key Principles in Safely Prescribing Bispecific Antibodies in Heavily Pretreated Patients With Multiple Myeloma (Part 1)
Faculty
Josh Epworth, MSN, ARNP
New!
Key Principles in Safely Prescribing Bispecific Antibodies in Heavily Pretreated Patients With Multiple Myeloma (Part 2)
Faculty
Josh Epworth, MSN, ARNP
New!
Treatment Selection and AE Management in Follicular Lymphoma
Faculty
Jennifer L. Garson, PA-C
New!
Considerations in Front-Line Treatment Selection for CLL
Faculty
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
New!
BTK Inhibitors Beyond CLL: Their Role in the Treatment of Select B-Cell Malignancies
Faculty
Laura J. Zitella, MS, RN, ACNP-BC, AOCN
New!
Case Studies in Myeloid Disorders: The Advanced Practitioner's Role in Patient Management
Faculty
Allyson Price, MPAS, PA-C
New!
Managing CLL Patients Receiving BTK Inhibitor Treatment: Considerations for Advanced Practitioners
Faculty
Jill Miller, MS, PA-C
New!
The Role of the Advanced Practitioner in Managing Painful Bone Metastases With RFA
Faculty
Jeannine M. Brant, PhD, APRN-CNS, AOCN, FAAN
If you enjoyed these Clinical Case Series modules, check back often to see more on new topics.
Let us know what you'd like to learn more about at editor@advancedpractitioner.com